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Abstract
Malignant transformation involves an orchestrated rearrangement of cell cycle regulation mechanisms that must
balance autonomic mitogenic impulses and deleterious oncogenic stress. Human papillomavirus (HPV) infection is
highly prevalent in populations around the globe, whereas the incidence of cervical cancer is 0.15%. Since HPV
infection primes cervical keratinocytes to undergo malignant transformation, we can assume that the balance
between transforming mitogenic signals and oncogenic stress is rarely attained. We showed that highly transforming
mitogenic signals triggered by HRasG12V activity in E6E7–HPV–keratinocytes generate strong replication and oxidative
stresses. These stresses are counteracted by autophagy induction that buffers the rapid increase of ROS that is the
main cause of genotoxic stress promoted by the oncoprotein. As a result, autophagy creates a narrow window of
opportunity for malignant keratinocytes to emerge. This work shows that autophagy is crucial to allow the transition of
E6E7 keratinocytes from an immortalized to a malignant state caused by HRasG12V.

Introduction
In developing and adult organisms, a dynamically
orchestrated molecular network of stress response pathways underlies the robust homeostasis of somatic cells1.
However, uncontrolled proliferation permanently compromises the cancer cell’s robustness, overburdening its
system of stress response pathways. This fragile balance
between uncontrolled proliferation and the overloaded
stress response is a phenotypic trait common to cancer
cells2,3. During the onset and development of oncogenesis, cells in the transition to malignant transformation
phenotype must adapt their stress response pathways to
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new demands of an uncontrolled proliferation surge,
which lead to growing tumors or cell death.
Cervical cancer is the fourth most common cancer in
women. In 2018, this disease affected 570,000 women
killing 311,0004. Prior HPV infection renders cervical
keratinocytes prone to malignant transformation driven
by Ras oncogene mutations5. Ras is a small GTPase
responsible in connecting the signal transduction from
membrane tyrosine kinase receptors to protein kinase
cascades6. The KRas isoform is found in 75% of all cases
of cancer in which Ras is mutated7,8; nevertheless, in
HPV-primed keratinocytes, leading to head–neck and
cervical cancers, HRas plays an important role9–11.
Although HPV is the most common sexually transmitted disease, only a small proportion of infected women
develop cervical cancer or its precursor lesions4,5. This
implies that, in vivo, human HPV-primed keratinocytes
must undergo severe oncogenic stress during oncogenesis.
To experimentally analyze this phenomenon, we evaluated
a cell culture model of malignant transformation. As a ﬁrst
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and necessary step, primary cultures of human keratinocytes were previously immortalized by constitutive
expression of E6E7/HPV16 genes, which promote degradation of p53 and pRb proteins. Posteriorly, the E6E7
keratinocytes were subjected to malignant transformation
triggered by HRasG12V expression12–14. However, the
molecular mechanisms underlying the transition from
immortalized to malignant transformed E6E7/HPV keratinocytes were not identiﬁed, particularly the role of
autophagic pathways15.
Autophagy is a prosurvival mechanism responsible for
the degradation and recycling of cytosolic contents,
including protein complexes and organelles16. This process can provide substrates to keep cellular homeostasis in
cases of high energetic and anabolic demand regularly
found during oncogenesis17 (e.g., to maintain nucleotide
pools18). Moreover, autophagy promotes clearance of
dysfunctional mitochondria in cancer cells preventing the
accumulation of reactive oxygen species (ROS)19. Nonetheless, uncontrolled autophagic ﬂux can also promote
cell death20–23.
Here, we report quantitative analyses of a cell culture
model consisting of an E6E7/HPV-immortalized human
keratinocyte (hereafter E6E7 keratinocytes) conditionally
subjected to ER:HRasG12V expression upon 4OHtamoxifen (4OHT) induction. This experimental design
allowed ﬁne-tuning modulation of estrogen-receptorinducible form ER:HRasG12V activity, during the transition from immortalized to malignant transformed E6E7
keratinocytes.

Results

High HRasG12V activity caused severe oncogenic stress in
E6E7 keratinocytes

We transduced E6E7 keratinocytes with a constitutively
expressed HRasG12V oncogene construction aiming to
probe into a potential transformation barrier in this type
of human cells. Four days after HRasG12V transduction,
cells showed remarkably high levels of HRasG12V and PERK1/2 compared with control cells transduced with
empty vector control (EV) (Supplementary Fig. S1A). In
addition, HRasG12V-transduced cultures displayed aberrant morphology with several vacuoles, low proliferation,
and loss of viability (Supplementary Fig. S1B). However,
30 days after transduction, HRasG12V and P-ERK1/2 levels
markedly decreased in HRasG12V-transduced cells, and
signs of crisis were no longer observed. Moreover, by this
time, HRasG12V-transduced cells showed higher proliferation rates and increased saturation density compared
with EV (Supplementary Fig. S1C, S1D). These results
suggested that high HRasG12V levels in E6E7 keratinocytes
cause strong oncogenic stress, and may lead to the
selection of low-expressing HRasG12V keratinocytes with
malignant traits.
Ofﬁcial journal of the Cell Death Differentiation Association
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We transduced the ER:HRasG12V in E6E7 keratinocytes,
yielding the inducible sublineages (SLis) (Fig. 1A and
Supplementary Fig. S1E, S1F). 4OHT dose–response
curves showed ER:HRasG12V expression increasing from
negligible levels to a plateau at 50 nM of 4OHT (Fig. 1A).
The activation of the downstream proteins ERK1/2 and
Akt also peaked at 50 nM. To check whether the HRasG12V
activity was dependent on an external growth factor, we
induced ER:HRasG12V keratinocytes in two different media
compositions, with and without EGF and pituitary extract
supplementation. HRasG12V activity in the form of ER:
HRasG12V–GTP concentration was shown to be dependent on growth factor supplementation (Fig. 1B).
In complete media, doses of the inductor ranging from 5
to 100 nM impaired cell proliferation in a dose-dependent
manner (Fig. 1C). Moreover, the cytomorphological signs
of crisis were also dose-dependent on HRasG12V activity
(Supplementary Fig. S2A). Interestingly, in nonsupplemented culture media, the addition of 50 nM of
4OHT caused a slight growth increase over 10 days (Fig.
1D), whereas this concentration of the inductor blocked
cell proliferation and induced cell death by day four in
complete media (Fig. 1D, E). These results showed that
E6E7 keratinocytes are toxically sensitive to high levels of
HRasG12V activity.
ER:HRasG12V keratinocytes maintained in 20, 50, and
100 nM of 4OHT were all dead in 3–6 weeks (Supplementary Fig. S3A). However, cells maintained in 5 and
10 nM of 4OHT were resistant to HRasG12V-inducible
activity for 6 months. These survivor sublineages (LTE5
and LTE10) exhibited a relative ER:HRasG12V-induction
ceiling about tenfold lower than their parental inducible ER:
HRasG12V keratinocytes (Supplementary Fig. S3B). Moreover, it is noteworthy that after this long-term selection, ER:
HRasG12V induction with 5–50 nM of 4OHT no longer
caused cytotoxicity in the LTE5 (Supplementary Fig. S3C),
it rather increased saturation density (Supplementary Fig.
S3D), contrary to the inducible parental lineage ER:
HRasG12V keratinocytes (Supplementary Fig. S3E). Altogether, these results suggested that high HRasG12V activity
was a barrier hardly tolerated during the malignant transformation transition of E6E7 keratinocytes.
In E6E7 keratinocytes, high levels of HRasG12V activity
cause cell cycle arrest and late cell death

The cell proliferation inhibition caused by HRasG12V
activity in this ER:HRasG12V keratinocytes model (Fig. 2A)
likely involved cell cycle arrest. We pulse-labeled DNA
and analyzed the cell cycle dynamics (Fig. 2B–D). The
results showed that G1 → S transition was blocked after
24 h of 4OHT induction since the S-phase subpopulation
plummeted to negligible size by day 2. However, the
increased number of 4OHT-induced cells arrested in G2/
M indicated an additional cell cycle blockage. Intriguingly,
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Fig. 1 High HRasG12V activity causes oncogenic stress in the E6E7 keratinocytes grown in supplemented media. A Immunoblots: 4OHT
dose–response of ER:HRasG12V induction. The activity of HRasG12V was monitored by a RAS-GTP-binding assay, which leads to downstream activation
of P-ERK and P-Akt. B Immunoblots comparing ER:HRasG12V levels between supplemented (5 ng/mL of EGF and 5 µL/mL of pituitary extract) and
nonsupplemented media in ER:HRasG12V-keratinocyte cultures. The immunoblot of cells in the supplemented medium is a projection of the one
presented in A. The electrophoresis gel of cell lysates derived from cells grown in either supplemented or nonsupplemented media, was blotted in
the same membrane to allow comparison of ER:HRasG12V levels and HRasG12V-GTP (HRasG12V-GTP = HRasG12V activity) under both conditions. C
Growth curves of ER:HRasG12V keratinocytes in function of 4OHT concentration. The graph is representative of three independent experiments carried
out in duplicate. D Effect of 50 nM 4OHT in ER:HRasG12V keratocytes growing in supplemented or nonsupplemented media. The graph is
representative of three independent experiments carried out in duplicate. E Evolution of the sub-G1 population of ER:HRasG12V keratocytes growing
in complete medium induced or not with 50 nM of 40HT, measured by ﬂow cytometry after PI staining. The graph is representative of two
independent experiments. For ﬂow cytometry, 30 × 103 events were considered per condition and time point. Growth curves and the sub-G1
population are presenting data as mean (SD). Two-way ANOVA *P ≤ 0.05, **P ≤ 0.01, and ***P ≤ 0.001, Bonferroni post hoc.

immunoblotting results showed no alterations in the
levels of physiological inhibitors of G1-phase progression
(p19 and p16) in these 4OHT-induced cells (Fig. 2E).
The G2/M arrest suggested the presence of DNA
damage caused by the HRasG12V-induced activity. To
evaluate the presence of DNA damage in ER:HRasG12V
keratinocytes, we carried out a TUNEL assay. We found
that on the 6th day of induction with 50 nM of 4OHT,
cells displayed nearly 100% of TUNEL-positive cells (Fig.
3A and Supplementary Fig. S4).
A possible explanation for DNA breaks observed in ER:
HRasG12V keratinocytes is due to an over mitogenic signal
Ofﬁcial journal of the Cell Death Differentiation Association

triggered by high HRasG12V activity. High proliferative rates
enhance the replication stress present in tumor cells3,24. This
could lead to genomic instability and DNA breaks if the
replication stress response is not able to completely repair
the DNA damage, such as exposure of long tracts of singlestranded DNA (ssDNA), which is a primary signal of this
type of stress25. Thus, to verify the presence of replication
stress, we measured the ssDNA exposure through a nativeBrdU immunoﬂuorescence assay26. We found an increased
number of BrdU foci in DNA in 4OHT-induced cells from
days 1 to 8 (Supplementary Fig. S5); by day 6, 30% of cells
displayed more than 50 BrdU foci per cell; on the contrary,
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Fig. 2 Oncogenic stress induced by high HRasG12V activity in E6E7 keratocytes causes cell cycle arrest at G1/G0 and G2/M phases. A Growth
curve of ER:HRasG12V keratinocytes in the supplemented medium induced or not with 50 nM of 4OHT. The graph is representative of three
independent experiments carried out in triplicate. B Cell cycle proﬁle analyses of growing ER:HRasG12V keratinocytes, using 1-h pulse of EdU
incorporation and propidium iodide (PI) staining, showed a progressive decrease in DNA synthesis (red arrows) in cells induced with 50 nM 4OHT.
C DNA content proﬁles of growing ER:HRasG12V keratinocytes stained with PI, with or without 4OHT induction. D Steady-state growing ER:HRasG12V
keratinocytes were induced or not with 50 nM 4OHT at zero time: kinetics of the relative size of cell cycle-phase subpopulations; evidence of cell cycle
arrest at G1/G0 and G2/M phases only in 4OHT-induced cells. The graph is representative of four independent experiments, two PI single-labeled, and
two PI plus EdU double-labeled. All conditions and time points were carried out in duplicate. E Immunoblots showed intracellular levels of critical
components of cell cycle control pathways in growing ER:HRasG12V keratinocytes induced or not with 4OHT. For ﬂow cytometry, 30 × 103 cells were
considered per condition and time point. Data presented as a mean (SD). Two-way ANOVA *P ≤ 0.05, **P ≤ 0.01, and ***P ≤ 0.001, Bonferroni
post hoc.

uninduced cells exhibited negligible basal levels of BrdU foci
(Fig. 3B).
Kinetic ﬂow cytometry analyses of keratinocytes under
high HRasG12V activity showed cell death increase in a
dose-dependent manner from day 4 to day 10 of induction
(Fig. 3C). Furthermore, annexin-V/PI double-stained
proﬁles of cells induced with 50 nM of 4OTH for up to
10 days conﬁrmed cell death (Fig. 3D), which was not
rescued by the treatment with the caspase inhibitor
ZVAD (Fig. 3E), showing that the cell death is independent of caspase activity. Thus, these results presented the
progressive oncogenic stress crisis triggered by HRasG12V
overactivity in E6E7 keratinocytes, which comprises
replication stress, cell cycle arrest, and late cell death.
Oxidative stress underpinned the damaging effects of high
HRasG12V activity in E6E7 keratinocytes

DCF ﬂuorescence labeling indicated a HRasG12V dosedependent elevation of ROS in induced ER:HRasG12V
keratinocytes (Supplementary Fig. S6A). In addition,
Ofﬁcial journal of the Cell Death Differentiation Association

MitoSOX ﬂuorescence labeling evidenced mitochondrial
superoxide accumulation in induced cells (Supplementary
-Fig. S6B). These results conﬁrmed that HRasG12V activity
induced oxidative stress in E6E7 keratinocytes, suggesting
a causal role in the oncogenic stress crisis described.
Treatment with the ROS scavenger NAC (N-Acetyl
cysteine) reduced the levels of single-stranded DNA
accumulation induced by 50 nM 4OHT in ER:HRasG12V
keratinocytes (Supplementary Fig. S7). The phosphorylation of both p38 and H2AX was also decreased in the
presence of NAC, with no changes in the ERK activation
induced by HRasG12V activity (Fig. 4A). These results
conﬁrmed that HRasG12V activity induced oxidative stress
in E6E7 keratinocytes, which account for the oncogenic
stress crisis described and indicate that NAC attenuates
the replication stress/DNA damage induced by high
HRasG12V activity without affecting its mitogenic signaling. NAC alleviated the cell cycle arrest induced by
HRasG12V activity, partly relieving the cell proliferation
inhibition (Fig. 4B). Moreover, NAC partially rescued ER:

Cararo-Lopes et al. Cell Death and Disease (2021)12:194

Page 5 of 16

Fig. 3 The oncogenic stress triggered by high HRasG12V activity causes DNA damage leading to cell death. A TUNEL assays showed high
levels of DNA strand breaks (DSB) in cells after six days of 4OHT induction in a dose-dependent manner. Two groups of controls were used:
noninduced ER:HRasG12V keratinocytes and ER:ø-keratinocytes treated with 50 nM of 4OHT emphasizing that the increasing levels of HRasG12V, but not
4OHT, are responsible for DNA breaks, n = 100 cells per condition. The whole experiment (including the experimental controls and the other 4OHT
concentrations used), is presented in Supplementary Fig. S4. B In ER:HRasG12V keratinocytes, native chromatin-BrdU assay showed persistent sites of
single-stranded DNA (ssDNA) after six days of 50 nM 4OHT induction. For each condition and day analyzed, at least 50 nuclei were counted and
classiﬁed into three different phenotypes: normal ≤10 foci/nucleus, the initial stage of replication stress ≥10 ≤ 50 foci/nucleus, and advanced stage of
replication stress ≥50 foci/nucleus. The whole kinetic experiment is displayed in Supplementary Fig. S5. C Sub-G1 populations increased with dose
and time of HRasG12V induction. The graph is representative of two independent experiments carried out in duplicate. D Annexin-V/PI-ﬂow cytometry
analyses: ER:HRasG12V keratinocytes induced with 50 nM of 4OHT and the noninduced control condition were analyzed for 10 days. Density plots are
presented as an example of the proﬁle of ER:HRasG12V keratinocytes in days 6 and 8. E In the same kinetic design, the treatment with 25 µM of the
caspase inhibitor ZVAD did not rescue the viability of keratinocytes under high HRasG12V activity. The graphs are representative of three independent
experiments. For ﬂow cytometry, 30 × 103 cells were considered per condition and time point. Data presented as a mean (SD). One-way ANOVA for
B and two-way ANOVA for C and D. *P ≤ 0.05, **P ≤ 0.01, and ***P ≤ 0.001, Bonferroni post hoc.

HRasG12V keratinocytes from the cell death triggered by
high HRasG12V activity, as shown by sub-G1 subpopulation measurements (Fig. 4C) and annexin-V/PI assays
(Fig. 4D). Altogether, these results show that oxidative
Ofﬁcial journal of the Cell Death Differentiation Association

stress was a major cause of the oncogenic stress crisis
triggered by high HRasG12V activity in E6E7 keratinocytes,
which act in the cell cycle blockages at G1 → S transition
and G2/M phase (Fig. 4E).
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Fig. 4 The antioxidant NAC mitigated the toxic effects of HRasG12V activity, diminishing DNA damage and increasing cell viability.
A Immunoblots of ER:HRasG12V keratinocytes induced for 48 h with 50 nM 4OHT, treated or not with 5 mM of NAC. B Growth curves of ER:HRasG12V
keratinocyte induced or not, showing the protective effect of NAC on cell proliferation. The graph is representative of two independent experiments
carried out in duplicate. C DNA content by PI-ﬂow cytometry analyses showed that NAC increased cell viability, evidenced by the elimination of the
sub-G1 population on the 8th day of induction. The graph is representative of two independent experiments. D Annexin-V/PI-ﬂow cytometry cell
viability assays: quantiﬁed density plot graphs also demonstrated NAC survival effect on ER:HRasG12V keratinocytes induced with 4OHT. Density plots
are presenting the proﬁle of keratinocytes treated or not with 4OHT on their 8th day. The graph is representative of two independent experiments.
E PI-ﬂow cytometry cell cycle analyses showed that NAC-treated ER:HRasG12V keratinocytes could overcome the G1 and G2/M cell cycle arrest caused
by high HRasG12V activity. The signiﬁcance presented in the graph is related to the comparison between cells induced with 50 nM of 4OHT with (dark
green) or without (gray) NAC treatment. The graph is representative of two independent experiments. For ﬂow cytometry, 30 × 103 cells were
considered per condition and time point. Data presented as mean (SD). Two-way ANOVA *P ≤ 0.05, **P ≤ 0.01, and ***P ≤ 0.001, Bonferroni post hoc.

Autophagy buffers oncogenic stress triggered by HRasG12V
activity creating a survival and proliferative window for
malignant keratinocyte surges

Induced ER:HRasG12V keratinocytes microscopically displayed vacuoles that progressively increased in size and
quantity depending on 4OHT concentration and time of
induction (Supplementary Fig. S2). Immunoﬂuorescence
evidenced the colocalization of autophagic proteins p62 and
LC3 at days 4 and 6 (Fig. 5A) after HRasG12V induction. In
addition, immunoblotting kinetics showed increased levels
of LC3II, an indicator of autophagic activity, only after the
peak of 4OHT-induced HRasG12V expression (Fig. 5B).
These results showing autophagy upregulation following the increase in the oncogenic HRasG12V levels
Ofﬁcial journal of the Cell Death Differentiation Association

suggested that autophagy was triggered in response to
HRasG12V activity potentially to keep the cell viability. To
further investigate the role of autophagy in the induced
ER:HRasG12V keratinocytes, we used hydroxychloroquine
(CQ), an autophagy inhibitor. Immunoblotting for LC3II
revealed that 48 h of HRasG12V induction increased
autophagic initiation but when combined with CQ treatment also increased the accumulation of nonprocessed
autophagic labeled substrates, as shown by the accumulation of p62, suggesting that HRasG12V activity surpassed
the autophagic ﬂux limit (Fig. 6A)27,28. After 96 h of
HRasG12V induction combined with CQ, both the proliferation inhibition (Fig. 6B) and cell death (Fig. 6C)
drastically enhanced.
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Fig. 5 Autophagic ﬂux was increased 48 h after HRasG12V induction. A Forty-eight hours after HRasG12V induction, immunoﬂuorescence assays
(IFA) exhibited the onset of the two autophagic markers LC3 and p62, which colocalized the surrounding vacuoles, suggesting a cause-and-effect
relationship between HRasG12V activity and autophagy initiation. B The kinetics of this phenomenon was further clariﬁed by immunoblots that
showed HRasG12V induction at 24 h followed by LC3II expression at 48 h (see red arrows), implying that the autophagy initiation was in response to
the oncogenic stress caused by HRasG12V activity.

We established an ER:HRasG12V keratinocyte sublineage
defective in autophagy by knocking out the gene encoding
the protein ATG7 using the CRISPR–Cas9 system. In
contrast with the scramble control cells (hereafter Scrb
keratinocytes), the resultant knocked-out sublineage (hereafter ΔATG7 keratinocytes) showed undetectable levels of
ATG7 and no autophagy activation when induced (Fig. 6D).
Upon HRasG12V induction, ΔATG7 keratinocytes failed to
process LC3I–LC3II, and the p62 levels were increased
compared to Scrb keratinocytes, conﬁrming successful
ablation of the autophagic pathway. In addition, HRasG12V
induction and MAPK–ERK1/2 activation were similar in
Scrb- and ΔATG7 keratinocytes, showing that the pattern
Ofﬁcial journal of the Cell Death Differentiation Association

of HRasG12V induction and mitogenic activation were preserved. ΔATG7 keratinocytes turned out to be extremely
sensitive to the oncogenic stress initiated by HRasG12V
activity. Growth curves showed that the proliferation of
ΔATG7 keratinocytes was strongly inhibited even by 5 nM
of 4OHT induction, which was well tolerated by parental
ER:HRasG12V keratinocytes or Scrb keratinocytes (Fig. 6E,
5 nM). This increased sensitivity to HRasG12V activity in
ΔATG7 keratinocytes was even more pronounced in higher
concentrations of 4OHT (Fig. 6E, 20 and 50 nM). Moreover, annexin-V/PI assays demonstrated that ΔATG7 keratinocytes under induction died earlier and at higher rates
than Scrb keratinocytes (Fig. 6F).
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(see ﬁgure on previous page)
Fig. 6 Autophagy promoted survival in keratinocytes under oncogenic stress triggered by HRasG12V activity. A Immunoblots of ER:HRasG12V
keratinocytes presenting autophagy markers (LC3II and p62) under 48 h of CQ (5 µM) treatment induced or not with 4OHT (50 nM). B The growth
curve of induced ER:HRasG12V keratinocytes suggests loss of cell viability of keratinocytes that had their autophagy ﬂux inhibited. The graph is
representative of three independent experiments carried out in duplicate per condition and time point. C DNA content analysis by ﬂow cytometry
using PI of labeled ER:HRasG12V keratinocytes showed a drastic increase of sub-G1 population in 4OHT-induced keratinocytes treated with CQ. The
graph is representative of two independent experiments. D Immunoblots of ER:HRasG12V autophagy-defective keratinocytes (ΔATG7 keratinocytes)
and their control autophagy-competent scrabble (Scrb keratinocytes). The absence of ATG7 and LC3II in ΔATG7 keratinocytes induced with 50 nM
4OHT conﬁrmed successful knockout of the ATG7 gene and ablation of the autophagy pathway. E Growth curves using different 4OHT
concentrations and consequently different levels of HRasG12V activity. The graph is representative of three independent experiments carried out in
duplicate. F Flow cytometry of cell viability assay stained with annexin-V/PI. Density plot graphs (8th day) and their quantiﬁcation indicate that
autophagy activity is crucial for keratinocyte survival under oncogenic stress promoted by HRasG12V activity. The graph is representative of two
independent experiments in which 30 × 103 cells were considered per condition and time point. Data presented as a mean (SD). Two-way ANOVA,
*P ≤ 0.05, **P ≤ 0.01, and ***P ≤ 0.001, Bonferroni post hoc.

The results of Figure 4 indicated that ROS generation
was the main cause of oncogenic stress triggered by
HRasG12V activity. These results also suggested that
autophagy upregulation was a prosurvivor response,
aiming to keep cell viability. Furthermore, immunoblot
showed that HRasG12V-induced keratinocytes displayed
reduced levels of autophagy when cells were treated with
NAC (Fig. 4A, LC3II). We compared the levels of ROS
between ΔATG7 keratinocytes and Scrb keratinocytes. By
48 h of induction, HRasG12V activity increased ROS levels
in about 20% in the Scrb keratinocytes (Fig. 7AI, BI);
markedly, in ΔATG7 keratinocytes, HRasG12V activity
resulted in over 70% increase (Fig. 7AII, BII). Such elevation in the ROS levels was not found in autophagycompetent keratinocytes, even in longer time points after
induction (Fig. 7AIII, BIII). Further linking the oxidative
stress to the observed autophagy, NAC treatment partially prevented ROS acute increase in ΔATG7 keratinocytes, protection even higher than in Scrb keratinocytes
after HRasG12V induction, showing that the ROSbuffering effect was dependent on autophagic activity
(Figs. 7A, BI, BII).
Besides the autophagy-buffering effects on ROS, elevated
glycolytic levels suggested that autophagy could also be
recruited in consequence of a metabolic imbalance in
keratinocytes upon high HRasG12V activity (Fig. 7C). In
these conditions, autophagy can be mobilized to relieve this
metabolic imbalance by supplying cells with essential
substrates18,29. Thus, we fed induced ER:HRasG12V keratinocytes with deoxynucleosides for 6 days. Deoxynucleoside
feeding rescued ER:HRasG12V keratinocytes from death but
did not recover cell proliferation, suggesting that nucleotide pool deregulation was part of the oncogenic stress
triggered by high HRasG12V activity (Fig. 7D).
Altogether, these results revealed that autophagy prevents HRasG12V-dependent rapid ROS generation, opening a window for survival and proliferation of E6E7
keratinocytes under stress caused by high HRasG12V
activity. This window would allow the selection of
Ofﬁcial journal of the Cell Death Differentiation Association

malignant HPV-primed keratinocytes, making autophagy
a tumor promoter agent in this context (Fig. 8).

Discussion
Mutated HRas is found in approximately 230,000 cases
of cancer globally11. However, as we have shown, the
oncogenic potential of mutated HRas is limited by its own
activity. We demonstrated that different levels of
HRasG12V activity are responsible for different cell fates,
which were determined by the oncogenic stress levels
tolerated by keratinocytes. In E6E7 keratinocytes, high
HRasG12V activity initiated a chain of stresses, leading to
discoordination of the mitogenic signaling that propagates
to replication impairment and oxidative stress, both
responsible for DNA damage.
We demonstrated that elevated HRasG12V activity
strongly signaled cell cycle progression as indicated by
MAPK stimulation and p16 and p19 inhibition (Fig. 2D,
C). Paradoxically, 48 h after induction rather than progressing, the keratinocytes remained blocked in the
G1/G0 phase (Fig. 2), exhibiting symptoms of mitogenic
stress. Ras is a causative agent of mitogenic stress since it
can deregulate cell cycle checkpoints through the Raf/
MEK/ERK axis30,31. Besides, sustained Ras activity can
mediate genomic instability32. In this scenario, genomic
instability was caused by defects in the spindle assembly
checkpoints that became an important source of DNA
damage signaling to p53, which resulted in interruption
of cell cycle progression and potentially in cell death32.
In lung cells, the transition from hyperplastic to malignant phenotype is associated with genomic instability
that positively selects cells with p53-inactivating mutations33. Furthermore, functional p53- signaling is the
base to explain the better prognostics found in HPVhead–neck cancers in comparison with HPV + ones
from the same type34,35.
In the case of E6E7 keratinocytes, p53 and pRb were
degraded by E6E7/HPV proteins (Supplementary Fig.
S1G, S1H, S1I); however, these cells under high HRasG12V
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Fig. 7 Autophagy buffers the levels of ROS, reducing the DNA damage caused by oxidative species, hence increasing the survival of
keratinocytes transitioning to a malignant transformed phenotype. A Flow cytometry measurements of reactive oxygen species (ROS) through
DCF ﬂuorescence. Autophagy-competent (Scrb keratinocytes I–III) and autophagy-deﬁcient keratinocytes (ΔATG7 keratinocytes II–IV) were induced
with 50 nM 4OHT and treated with 5 mM NAC for 48 h (I, II) or 96 h (III, IV). The red brackets show the gradual increase in ROS levels in autophagycompetent cells and the fast increase of ROS levels in keratinocytes lacking autophagy. B ΔATG7 keratinocytes increase in 70% of their ROS levels
after 48 h of HRasG12V induction. The levels in autophagy-competent keratinocytes were much lower (20%). In addition, NAC treatment reduced
steady-state levels of ROS in noninduced keratinocytes. The dislocation of the ﬂuorescent population was quantiﬁed by the Kolmogorov–Smirnov
test (K–S). The graphs are representative of three independent experiments. C The conditioned culture media of ER:HRasG12V keratinocytes, 4OHTinduced and noninduced (control), were harvested for 10 days and had their lactate concentration measured. The graph is representative of two
independent experiments carried out in triplicate. D The ﬂow cytometry of cell viability assay stained with annexin-V/PI showed that deoxynucleoside
treatment improved keratinocytes’ survival under oncogenic stress promoted by HRasG12V activity. The ER:HRasG12V keratinocytes were plated in lower
density to extend as much as possible the experiment. After 6 days, the cells were induced with 50 nM 4OHT, treated with 2 mM deoxynucleosides
(deoxyadenine, -guanosine, -cytidine, and thymidine) and their respective controls had their viability measured. The graph is representative of two
independent experiments. The different font sizes represent the intensity of the effect. For ﬂow cytometry, 30 × 103 cells were considered per
condition and time point. Data presented as a mean (SD). Two-way ANOVA, *P ≤ 0.05, **P ≤ 0.01, and ***P ≤ 0.001, Bonferroni post hoc.

activity were driven to cell cycle arrest followed by death.
We hypothesize that the genomic instability due to sustained high HRasG12V activity is the cause of a genomic
crisis that typically occurs in cells transitioning to the
malignantly transformed stage that is characterized by
mitotic arrest, hyperstimulation of autophagy, and cell
death15,36, events systematically present in E6E7 keratinocytes under high HRasG12V activity as we have shown
(Figs. 2 and 5). Moreover, the degradation of p53 (Supplementary Fig. S1H) and the high index of cell death
under high HRasG12V activity, even when the caspase
inhibitor ZVAD is used (Fig. 3E), suggested that the
genomic crisis allied to high levels of ROS might be
responsible for a nonapoptotic cell death independent on
Ofﬁcial journal of the Cell Death Differentiation Association

caspase activation. Besides, annexin-V/PI assays showed
that the wide majority of nonviable keratinocytes are
double-labeled (Figs. 3D, 4D, and 6F), which is consistent
with abrupt rupture of the cytoplasmatic membrane that
is one of the main hallmarks of necrosis37. To conclude,
the high levels of ROS (Fig. 6), the rescue of cell viability
using the ROS scavenger NAC, and the potential metabolic imbalance (Figs.4 and 7C/D) allow us to propose
that ferroptosis, a speciﬁc form of regulated necrosis38,
might have been trigged as an additional tumor suppressor mechanism that superposes the deﬁciency of
canonical checkpoint signaling when E6E7 keratinocytes
are exposed to high HRasG12V activity, but further evidence is necessary to support such proposal.

Cararo-Lopes et al. Cell Death and Disease (2021)12:194

Page 11 of 16

Fig. 8 HPV-primed keratinocytes require autophagy to counteract the oncogenic stress triggered by HRasG12V activity during the
malignant transformation transition. A Step-by-step of the models generated and the role of HRasG12V activity in their fates. Note that the
different levels of inducible ER:HRasG12V activity are mimicking the fates observed in the constitutive ones. In the constitutive model, we could
observe only the product of a random selection of cells presenting low levels of HRasG12V activity. Nonetheless, using the inducible model, we were
able to observe the phenomenon responsible for such selection. B Mechanistic model presenting the challenge that HPV-primed keratinocytes, in
the transition to a malignant transformed phenotype, must bypass according to the intensity of oncogenic stress (ROS, imbalanced metabolism,
replication stress, and DNA damage). The intensity of the oncogenic stress is determined by different levels of HRasG12V activity and it is
counterbalanced by autophagic activity in a different fashion: (I) only a moderate level of HRasG12V activity is supported by immortalized E6E7
keratinocytes since the autophagy activity, also moderate, is capable of buffering the oncogenic stress generated. (II) However, without the
recruitment of autophagy, any level of oncogenic stress is not tolerated, proving that autophagy is recruited primarily as a safeguard mechanism. (III)
On the other hand, high levels of HRasG12V activity generate unbearable oncogenic stress followed by the activation of autophagy over the cell
capacity of processing that becomes an additional source of stress leading to cell death. The different font sizes are expressing the levels of cell
signaling/events observed.
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Another source of DNA damage caused by high HRasG12V
activity is the replication stress that could be compounded
by different molecular events: increased ﬁring origin of
replication, impaired fork progression39,40, depleted
nucleotide pool41, and stimulated replication–transcription
conﬂicts42. Nonetheless, our ﬁndings suggested that the
predominant factor that led to replication impairment and
DNA damage was oxidative stress. We demonstrated that
E6E7 keratinocytes under high HRasG12V activity treated
with NAC considerably reduced the levels of ssDNA and
γH2AX (Supplementary Fig. S7 and Fig. 4A), allowing these
cells to overcome the G1/G0 blockage, to progress
throughout the S phase, and delay the blockage in G2/M
(Fig. 4E).
We showed that the limited improvement observed in
NAC treatment was linked to autophagic activity as suggested by LC3II- and ROS-reduced levels in induced
keratinocytes treated with NAC (Figs. 4A and 7A/B).
Autophagy buffers the acute generation of ROS caused by
HRasG12V activity enhancing the keratinocyte viability. In
autophagy-competent E6E7 keratinocytes (Scrb keratinocytes), the ROS levels increased but never reached the
threshold of autophagy-deﬁcient E6E7 keratinocytes
(ΔATG7 keratinocytes). We hypothesized that the main
source of the observed ROS is mitochondria, as suggested
by the increased levels of mitochondrial superoxide
(Supplementary Fig. S6A). Besides, oncogenic stress can
cause DNA damage mediated by mitochondrial
ROS19,43,44. Moreover, mitophagy is an important
mechanism to prevent the surge/increases of ROS
clearing-damaged mitochondria22,45–47. Thus, we proposed that in E6E7 keratinocytes under HRasG12V activity,
autophagy could be acting in the clearance of damaged
mitochondria softening the deleterious effects of ROS47,48.
The context dependence of autophagy in cancer cells
has been largely discussed22,49–52. Some authors attribute
to autophagy a potential for cell death driving38,53; however, in most cases where autophagy is associated with cell
death, the mechanism is activated as a prosurvival
attempt54. Here, we are proposing that in E6E7 keratinocytes, autophagy was recruited as a prosurvival
mechanism to mitigate the oncogenic stress caused by
HRasG12V activity; however, only in moderate oncogenic
activity, the mechanism can support the transition from
immortalized to the malignant transformed phenotype.
This is a convincing proposition when we consider that
E6E7 keratinocytes were unviable under any level of
HRasG12V activity when autophagy was blocked (Fig. 6).
Despite the essential role of autophagy in keratinocytes
transitioning from immortalized to malignant state, its
intense and continuous recruitment overloaded the system causing an uncontrolled ﬂux (Figs. 5B and 6D),
demonstrated by the accumulation of p62 (Figs. 5A and
6A/D). The accumulation of p62 by itself is highly toxic,
Ofﬁcial journal of the Cell Death Differentiation Association
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causing even more generation of ROS, which might
contribute to the phenotype observed55,56. Therefore, we
concluded that autophagy is initiated as a protective
mechanism increasing cell survival; however, sustaining
intense autophagic induction caused by acute ROS surges
generates an autophagic ﬂux beyond the cell processing
capacity. As a result, autophagy became an additional
source of stress.
Finally, cells exposed to HRasG12V activity can be aided
by metabolic reprogramming increasing the glycolytic
activity through the MAPK and PI3K axes. This metabolic
reprogramming helps in the generation of biomass such
as amino acids and nucleotides57. Our results showed that
E6E7 keratinocytes under HRasG12V activity highly signaled MAPK and PI3K, and might be responsible for a
metabolic shift (Figs. 1A, 2E, 4A, and 6D). In addition, the
increased concentration of lactate in the cell culture
medium suggested that E6E7 keratinocytes under high
HRasG12V activity were pushed to reprogramming its
metabolism to aerobic glycolysis. Likewise, the elevated
mitogenic signal could increase the number of DNA
replication origins ﬁred, further stressing the limited
levels of deoxynucleotide pools causing genomic
instability and consequent loss of cell viability58. As
shown in Fig. 7D, treatment with deoxynucleosides partially rescued the viability of induced keratinocytes.
In conclusion, our results showed that high levels of
HRasG12V activity are not tolerated by E6E7 keratinocytes
under any circumstances for two reasons: ﬁrst, deleterious
levels of mitogenic, replication, and ROS stresses
responsible for high genotoxicity; second, recruitment and
activation of autophagy beyond the processing capacity of
the cell system, causing accumulation of toxic content not
properly processed (Fig. 8). These results per se are proposing an alternative molecular approach to defeat
malignantly transformed cells, that consists in the imposition of even higher levels of mitogenic signals while
autophagy is blocked, which could be a promising therapeutic strategy when limiting cell growth using mitogenactivated protein kinase inhibitors proves to be ineffective
or refractory.

Methods
Transduction, parental cells, and sublineage cultures

All parental cells and sublineages listed below were
grown in KSFM medium (Thermo Fisher®) supplemented
with recombinant epidermal growth factor 5 ng/ml,
bovine pituitary extract 50 mg/ml (except when otherwise
indicated) and incubated at 37 °C in 5% CO2 atmosphere.
Immortalization of primary human keratinocytes with
E6E7–HPV16 proteins

Primary foreskin human keratinocytes (PHK) (Lonza
Walkersville, Inc., Walkersville, MD) were transduced
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with pLXSN-encoding E6E7–HPV16 proteins. After 24 h
of acute transduction, transduced keratinocytes were
selected using 300 µg/mL of G418. The retrovirus pLXSN
was kindly provided by Dr. Denise Galloway (Fred
Hutchinson Cancer Research Center, Seattle, WA), which
was previously described59.
Constitutive (SLcs) and inducible (SLis) keratinocyte
sublineages

PHK immortalized by E6E7/HPV16 proteins was transduced with retrovirus constructs for 48 h. pBabepuroHRasG12V was utilized for constitutive expression (SLcs)
and pBabepuro-ER:HRasG12V, for inducible expression sublineages (SLis) (Supplementary Fig. S1). After this period,
transduced cultures were selected using 2.5 µg/mL of puromycin (Invitrogen©). Three independent clones were generated for each sublineage. Additionally, two independent
empty controls were generated pBabe-ø and pBabe-ER:ø for
constitutive and inducible sublineages, respectively. Concentrations from 5 nM to 100 nM of 4OHT proved to be
innocuous in the parental E6E7 keratinocytes and ER:økeratinocytes (Supplementary Fig. S1 J/L) emphasizing that
the results obtained are exclusively related to HRasG12V
activity and not the inductor 4OHT. All treatments, concentrations, and vehicles of dilution (used in the controls)
are indicated in Supplementary Table 1.
Cas9-mediated ATG7 knockout

To knock out the ATG7 gene in ER:HRasG12V keratinocytes, we designed and tested two different gRNAs
(ΔATG7I and ΔATG7II) using the CRISPR design tool
(http://crispr.mit.edu/). A control gRNA (Scrb keratinocytes) that normally expresses ATG7 was also designed.
The sequences are presented in Supplementary Table 1.
Oligos were cloned into the LentiCRISPR v2 plasmid (a
gift from Feng Zhang, Addgene plasmid # 52961) as
described in Sanjana et al.60. For lentivirus production,
LentiCRISPR v2 constructs, psPAX2 (a gift from Didier
Trono, Addgene plasmid # 12260), and pCMV-VSV-G (a
gift from Bob Weinberg, Addgene plasmid # 8454) were
transfected into HEK293T cells using lipofectamine 3000
reagents according to the manufacturer’s protocol. Fortyeight hours after transfection, viral supernatant was collected, ﬁltered, and applied to ER:HRasG12V keratinocytes
after the addition of 8 µg/ml polybrene. The knockout was
tested after 7 days since both gRNAs showed a high
efﬁciency; all the experiments were performed using the
sublineage ER:HRasG12V keratinocyte–ΔATG7I, hereafter
ΔATG7 keratinocytes.
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determine P0. This procedure was done to eliminate the lag
phase of these cells and observe the effects of treatment and/
or induction in the exponential phase. For maximum cell
density saturation assays, 20 × 103 cells/cm2 were plated.
After 10 days (P10), the cultures reached their saturation
density. The induction using 4-hydroxytamoxifen (4OHT)
was initiated in P0, for the growth curve, and P10, for cell
saturation density assays. In the days indicated cells were
harvested using trypsin and resuspended in PBS + 5% fetal
bovine serum (FBS) to inactivate the trypsin, washed, and
ﬁxed in a solution of phosphate buffer (PBS) with 3.7% of
formaldehyde. All treatments and fresh medium were
changed every other day. The cells were counted in Beckman Counter Z2®. The graphs present the results of at least
two biological replicates in which three technical replicates
for each treatment were collected.
Western blots

The cells were plated in 60-mm2 Corning® dishes and
treated according to each experiment. The total protein
was extracted and isolated in RIPA buffer (SigmaAldrich®) plus HaltTM Protease Inhibitor Cocktail
(Thermo Fisher®). The samples were quantiﬁed using
Precision RedTM (Cytoskeleton®) and submitted to western blot. Western blots were performed by standard
chemiluminescence method using SuperSignal® and
Pierce ECL® (Thermo Fisher®). The images were obtained
by the UVITEC® equipment and analyzed by the Alliance® software. All the primary and secondary antibodies
are listed in Supplementary Table 2.
Pull down of Ras-GTP

Raf1 RBD agarose beads were incubated with 200 µg of
the extract of total protein for 2 h at 4 °C in low rotation.
Afterward, the beads attached to Ras-GTP were washed 8
times with PBS plus protease inhibitors. The beads were
resuspended in NuPAGETM sample buffer (Thermo
Fisher®) and applied to the acrylamide gel (12%). The
western blot was performed using the anti-HRas antibody.
Real-time PCR

Total RNA was extracted from cell culture by RNeasy
kit (Qiagen®), quantiﬁed, converted to cDNA using MultiScribe RT kit (Thermo Fisher®), and submitted to realtime (RT)PCR. RT-PCR was carried out using the SYBR®
GREEN PCR Master Mix (Applied Biosystems™) combined to the primers listed in Supplementary Table 3 and
the StepOne Plus PCR system. The results were calculated
using the ΔΔCt method and then normalized by RPL19.

Growth curves and cell saturation density assay

Flow cytometry

For growth curve assays, 7 × 103 cells/cm2 were plated
(except when differently stated) in Costar® six-well plates.
Forty-eight hours later, a six-well plate was collected to

For the assays performed in the ﬂow cytometer, the cells
were plated in Costar® and proceeded as indicated by
each experiment. All samples were run in the equipment
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Attune NxT Blue-Red (Thermo Fisher®) collecting 30000
events in at least two biological duplicates. The raw data
were treated and analyzed by FlowJo® V10.2.
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to a digital camera (XM10, Olympus), and were analyzed
using Olympus- Cell F software (version 5.1.2640).
Analysis of DNA breaks using TUNEL assay

Cell cycle analysis

After the indicated period and treatment, cells were
harvested and ﬁxed in ice-cold 75% ethanol overnight at
4 °C. Fixed cells were washed twice in PBS, labeled with
100 µg/mL of propidium iodide (Thermo Fisher®), treated
with 50 µg/mL of RNAse A (Invitrogen®) for 30 min, and
then immediately submitted to ﬂow cytometry. The
quantiﬁcation of single-labeled cell cycle phases was
obtained by Watson pragmatic method61 using FlowJo®
V10.2. Cells were submitted to one hour of EdU pulse
using the Click-iT® Alexa Fluor 488 (Thermo Fisher®)
according to the manufacturer’s recommendations for
double-labeled cell cycle analysis.
Cell viability assay

The cell viability was obtained from two methods as
indicated in the experiments: sub-G1 population extracted
from the cell cycle analysis and by double-labeling using
Alexa Fluor® 488 annexin-V/PI Dead Cell Apoptosis Kit
(Thermo Fisher®). The double-labeling was performed
following the manufacturer’s recommendations.
Assessment of ROS levels

The cells were plated in Costar® six-well plates. After
48 h, the medium was replaced adding the treatments
according to each experiment. The cells were incubated
with 50 µM of 2′−7′-dichlorodihydroﬂuorescene diacetate
(DCFDA Thermo Fisher®) for 1 h to measure general
oxidative species, and 10 µM MitoSOX™ (Invitrogen®) for
30 min to assess the levels of mitochondria superoxide.
After the incubation period, the cells were harvested and
analyzed by ﬂow cytometry.
Measurement of lactate levels

The medium of 4OHT-induced and noninduced cells
was collected every other day during the growth curve
assessment. The media was centrifuged for 30 min at
14000 rpm in Centricon microtube cutoff 10 KDa
(Vivaspin 500 GE Healthcare®). In total, 300 µL of the
sample were collected in duplicates and kept at −80 °C
until day 10, the last day of the experiment. The lactate
concentration of all samples was measured at once following the manufacturer’s recommendations of the Lactate Assay Kit (Sigma-Aldrich®). The ﬁnal concentration
was normalized by the number of cells per cm2 of the well
from where the medium was obtained.
Immunoﬂuorescence (IF)

For all experiments listed below, the images were captured
using an Olympus BX51 ﬂuorescence microscope coupled
Ofﬁcial journal of the Cell Death Differentiation Association

To evaluate the presence of DNA break and compare
the keratinocyte sublineages exposed to different concentrations of 4OHT with their respective controls, we
used terminal deoxynucleotidyl transferase-mediated
dUTP-Fluorescein nick-end-labeling (TUNEL) technique
using the Apoptosis Detection System, Fluorescein kit
(Promega). In total, 4 × 103 cells/cm2 were plated onto the
coverslips. After 48 h of treatment, the cells were washed
with PBS and ﬁxed using 1% paraformaldehyde for
10 min. The coverslips were washed with PBS and permeabilized by the addition of 0.1% Triton X-100 for
10 min at 26 °C. In all, 0.1 M glycine was added for 5 min
to neutralize the remaining aldehyde groups. TUNEL
assay was performed according to the manufacturer’s
protocol. VECTASHIELD® Mounting Medium with
DAPI (Vector Labs) was added to be used as an antifade
mounting solution and to stain the nuclei.
Analysis of replication stress by BrdU native detection
assay

For detection of long fragments of single-stranded DNA
(ssDNA), a feature of replication stress, we grow keratinocytes in coverslips [induced with 50 nM 4OHT, noninduced
(control), treated and nontreated with 5 nM NAC] in the
presence of 50 mM 5-bromo-2’-deoxyuridine (BrdU) for
24 h to allow its incorporation into DNA. After that, we
washed the coverslip-containing cells using PBS and ﬁxed
them using 4% of paraformaldehyde diluted in PBS for
10 min at room temperature. Next, cells were washed with
PBS and permeabilized with 0.2% Triton-X 100 for 10 min
at room temperature. To ensure that all cells incorporated
BrdU, replicates of each condition were subjected to DNA
denaturation using 2 M HCl. Then, all samples were
washed, and BrdU was detected (when accessible) using αBrdU-rat (Abcam) for 3 h at room temperature, followed by
a 3-h incubation with the secondary antibody Alexa Fluor
555-conjugated goat anti-rat (Thermo Scientiﬁc). After that,
the coverslip-containing cells were washed using 1× PBS
and deposited on slides. VECTASHIELD® Mounting
Medium with DAPI (Vector Labs) was used to be an antifade mounting solution and to stain nuclear DNA.
Statistical analyses

Two-way or one-way ANOVA followed by Bonferroni
multiple-comparison test was employed when appropriate as indicated in ﬁgure legends. The data are presented as mean ± SD. The signiﬁcance is pointed as the
following: *P ≤ 0.05, **P ≤ 0.01, and ***P ≤ 0.001. All
statistical analyses and graphs were prepared using
GraphPad Prism 7 software. In ﬂow cytometry assays,
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the difference of the population distribution was calculated by the Kolmogorov–Smirnov statistic (K–S) in
FlowJo® V10.2.
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